Insiders who reported open-market trades in the last 12 months at the companies Brian Lian files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Greg Zante - $2.82M in VKTX purchases and sales in the last 12 months
Marianna Mancini - $2.73M in VKTX purchases and sales in the last 12 months
Brian Lian is a corporate insider, tracked as President & CEO, Director of Viking Therapeutics, Inc. (VKTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brian Lian submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Brian Lian been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($14.75M) across all tracked filings.
Brian Lian is President & CEO, Director of Viking Therapeutics, Inc. (VKTX). 4 SEC Form 4 filings on record going back to 2025, most recently on 30 July 2026. Most recent open-market trade: sold $4.95M of VKTX on 30 July 2026. Lifetime open-market sales: $14.75M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Brian Lian.
InsiderAlpha's records for Brian Lian go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
